← Back to Search

Behavioural Intervention

Mindfulness Intervention for Post-COVID Syndrome

N/A
Waitlist Available
Led By Ivana Croghan, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-baseline
Awards & highlights

Study Summary

This trial will study if using a brain sensing wellness device to learn meditation can help decrease stress and anxiety for post-Covid patients with lengthy symptoms.

Who is the study for?
This trial is for individuals who have had COVID-19 and are now experiencing long-term symptoms. Participants must not be pregnant, should have access to a smartphone or tablet, and be able to fully participate in the study. They should not have any health conditions that would affect using the Muse S™ headband and not be on unstable medication doses.Check my eligibility
What is being tested?
The trial is testing whether a wearable brain sensing device called Muse S™ can help reduce stress and anxiety in people with lingering post-Covid symptoms by teaching them meditation practices.See study design
What are the potential side effects?
While there may not be direct side effects from using the Muse S™ headband, participants might experience discomfort or frustration if they find it difficult to engage with mindfulness practices.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reducing Anxiety
Reducing Stress

Trial Design

1Treatment groups
Experimental Treatment
Group I: Muse S™ Headband system for post-Covid SyndromeExperimental Treatment1 Intervention
Subjects will utilize the Muse S™ Headband system at least 4 times per week for a minimum of 10 minutes each time over a period of 3 months (12 weeks).

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,767,023 Total Patients Enrolled
Ivana Croghan, PhDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
23 Total Patients Enrolled
Ryan Hurt, MD, PhDStudy ChairMayo Clinic
3 Previous Clinical Trials
87 Total Patients Enrolled

Media Library

Muse S™ Headband system (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05199233 — N/A
Post-COVID Syndrome Research Study Groups: Muse S™ Headband system for post-Covid Syndrome
Post-COVID Syndrome Clinical Trial 2023: Muse S™ Headband system Highlights & Side Effects. Trial Name: NCT05199233 — N/A
Muse S™ Headband system (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05199233 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being accepted to the clinical study at this time?

"Affirmative. According to information located on clinicaltrials.gov, this inquiry is actively enrolling subjects. It was first posted on June 1st 2022 and last modified shortly thereafter on the 2nd of June 2022. Currently there are 60 positions open across a single site for those wishing to participate in the study."

Answered by AI

Is this research effort actively seeking participants?

"Per the details available on clinicaltrials.gov, this trial is open for patient recruitment. It was first introduced to the public record on June 1st 2022 and has been updated as recently as June 2nd of that same year."

Answered by AI

Who else is applying?

What state do they live in?
Kentucky
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~2 spots leftby Jun 2024